Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | RYZ101 |
Synonyms | |
Therapy Description |
RYZ101 is a radioconjugate comprising a somatostatin analog linked to Actinium-225, which delivers radiation to tumor cells expressing SSTRs, potentially resulting in cytotoxic effects (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
RYZ101 | RYZ-101|RYZ 101|225Ac-DOTA-TATE RYZ101 | RYZ101 is a radioconjugate comprising a somatostatin analog linked to Actinium-225, which delivers radiation to tumor cells expressing SSTRs, potentially resulting in cytotoxic effects (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05477576 | Phase Ib/II | Everolimus Lanreotide acetate RYZ101 Sunitinib Octreotide acetate | Study of RYZ101 Compared With SOC in Pts With Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy (ACTION-1) | Recruiting | USA | 0 |